Safety and Efficacy Trial of RPC1063 for Moderate to Severe Ulcerative Colitis

NCT02435992 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

1012

Enrollment

INDUSTRY

Sponsor class

Conditions

Ulcerative Colitis

Interventions

DRUG: RPC1063
DRUG: Placebo

Sponsor

Celgene